| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 11 |
| 1 | RANITIDINE | 10 |
| 2 | ERGOCALCIFEROL | 4 |
| 3 | NIRAPARIB | 4 |
| 4 | PREDNISONE | 4 |
| 5 | RANITIDINE HYDROCHLORIDE | 4 |
| 6 | VEDOLIZUMAB | 4 |
| 7 | ACETAMINOPHEN | 3 |
| 8 | ACETAMINOPHEN 500MG | 3 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRODALUMAB | 1 | 0.0005 |
| 1 | DANAZOL | 1 | 0.0004 |
| 2 | C1 ESTERASE INHIBITOR RECOMBINANT | 2 | 0.0003 |
| 3 | ASCIMINIB | 1 | 0.0003 |
| 4 | HYDROCORTISONE SODIUM SUCCINATE | 1 | 0.0003 |
| 5 | GILTERITINIB | 1 | 0.0002 |
| 6 | POLATUZUMAB VEDOTIN | 2 | 0.0002 |
| 7 | STERILE WATER FOR INJECTION | 1 | 0.0002 |
| 8 | NIRAPARIB | 4 | 0.0002 |
| 9 | TEPROTUMUMAB | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vitamin C [EPC] | 5 |
| 1 | Corticosteroid [EPC] | 4 |
| 2 | Integrin Receptor Antagonist [EPC] | 4 |
| 3 | Interleukin-23 Antagonist [EPC] | 4 |
| 4 | Kinase Inhibitor [EPC] | 4 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4 |
| 6 | Provitamin D2 Compound [EPC] | 4 |
| 7 | BCL-2 Inhibitor [EPC] | 3 |
| 8 | Benzodiazepine [EPC] | 3 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 4 | Hedgehog Pathway Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 6 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 7 | BCL-2 Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Integrin Receptor Antagonist [EPC] | 4 | 0.0000 |